Results 211 to 220 of about 24,588 (279)

Erratum: Influence of Omalizumab on Allergen-Specific IgE in Patients with Adult Asthma

, 2017
Hiroshi Mizuma, Akihiko Tanaka, Yoshitaka Uchida, A Fujiwara, Ryo Manabe, Hiromitsu Furukawa, Naomi Kuwahara, Y Fukuda, Takao Kimura, Megumi Jinno   +9 more
openalex   +1 more source

Global prevalence of eligibility for biologic therapy in ATS/ERS-defined severe asthma: A systematic review. [PDF]

World Allergy Organ J
Yang F, Salciccioli JD, Patel RE, McClean M, Bloom CI.   +4 more
europepmc   +1 more source

Severe chronic spontaneous urticaria responding and not responding to omalizumab: analysis of the prognostic value of known and novel in-vitro variables [PDF]

Riccardo Asero, Paolo Calzari, Silvia Mariel Ferrucci, M. Lorini, Vincenzo Carbonelli, S. Stella, D. Consonni, Massimo Cugno   +7 more
openalex   +1 more source

Specialist care improves diagnosis and treatment for patients with chronic spontaneous urticaria: A real-world survey. [PDF]

J Allergy Clin Immunol Glob
Mosnaim G, Hetherington J, Keal A, Holden M, Seetasith A.   +4 more
europepmc   +1 more source

Psychological and Related Factors Influencing Adherence to Biologic Therapies in Asthma: A Scoping Review. [PDF]

Curr Allergy Asthma Rep
Poletti V, Volpato E.
europepmc   +1 more source

Biologic Therapies and Quality of Life in Pediatric Patients with Asthma: A Systematic Review. [PDF]

Healthcare (Basel)
Vaz BL, Marrinhas D, Pereira A.
europepmc   +1 more source

Omalizumab-Induced Remission and Steroid Withdrawal in Refractory Eosinophilic Gastroenteritis with Severe Hypereosinophilia: A Case Report

Qian Guo, Weixun Zhou, J N Li, Li Ma, Qingli Zhu, Yuxiang Zhi   +5 more
openalex   +2 more sources

FDA-Approved Biologics for CRSwNP: A Five-Year Analysis of the FDA Adverse Event Reporting System. [PDF]

Laryngoscope Investig Otolaryngol
Duggal R, Chaaban MR.
europepmc   +1 more source

Omalizumab therapy for bullous pemphigoid

, 2014
Kenneth K. Yu, Ashley B. Crew, Kelly N. Messingham, Janet A. Fairley, David T. Woodley   +4 more
openalex   +2 more sources

Assessing the Value of Omalizumab for Pediatric Asthma in China: A Multicriteria Decision Analysis. [PDF]

Healthcare (Basel)
Yu Y, Cao W, Xiao Y, Wei J, Huang H, Li A, Zhao M, Hu L, Poonsiri C, Teerawattananon Y, Morton A, Guo P.   +11 more
europepmc   +1 more source